Contrasting roles of complement activation and its regulation in membranous nephropathy.
about
Alternative Pathway Dysregulation and the Conundrum of Complement Activation by IgG4 Immune Complexes in Membranous NephropathyComplement regulation in renal disease modelsMembranous nephropathy: from models to manLack of complement inhibitors in the outer intracranial artery aneurysm wall associates with complement terminal pathway activation.Murine membranous nephropathy: immunization with α3(IV) collagen fragment induces subepithelial immune complexes and FcγR-independent nephrotic syndrome.Presence of retinal pericyte-reactive autoantibodies in diabetic retinopathy patients.The role of complement in autoimmune renal disease.Dysregulated chemokine receptor expression and chemokine-mediated cell trafficking in pediatric patients with ESRD.Latest treatment strategies for membranous nephropathy.Upregulation of c-mip is closely related to podocyte dysfunction in membranous nephropathyNeonatal Fc receptor promotes immune complex-mediated glomerular disease.Pathogenesis of membranous nephropathy: recent advances and future challenges.The role of complement in membranous nephropathy.Immunopathogenesis of membranous nephropathy: an update.Biologics for the treatment of autoimmune renal diseases.Many drugs for many targets: novel treatments for complement-mediated glomerular disease.A podocyte view of membranous nephropathy: from Heymann nephritis to the childhood human disease.Melatonin enhances endogenous heme oxygenase-1 and represses immune responses to ameliorate experimental murine membranous nephropathy.HO-1 induction ameliorates experimental murine membranous nephropathy: anti-oxidative, anti-apoptotic and immunomodulatory effects.Fetomaternal alloimmunization with antenatal glomerulopathies.Anti-Phospholipase A2 Receptor Autoantibody: A New Biomarker for Primary Membranous Nephropathy.Experimental model of membranous nephropathy in mice: sequence of histological and biochemical events.Pathogenic role of effector cells and immunoglobulins in cationic bovine serum albumin-induced membranous nephropathy.
P2860
Q26747416-8864DDC5-B162-4897-871D-30DDFA7D0FE5Q33411137-FB8A27FE-AD50-4F98-92FC-95C76B7FD848Q33872569-85088505-55A1-43B0-AF83-B44478E81F87Q34358467-30ADAB9C-2E4E-4D0C-AC8B-71F3DEE6B7C5Q35851046-FDDBA00D-BDBE-4244-A121-F44CB832E0DEQ36536081-2937B833-8A87-434D-A07E-D53B42AAF555Q36573001-305810E0-9030-4481-927C-BBF5646996A4Q36666771-181FB068-6BC2-43F1-857E-EE5E837287E0Q37013035-9AF9240B-0959-4120-9C8C-EE2CCFA76FA4Q37590239-51494771-4BFE-4720-86B9-D0888816437FQ37733571-DC6B92D2-C52E-4E43-946E-6AA322677C3FQ37988806-138D2A81-F80A-48B9-AFDB-0C9EB40ECD74Q38155652-57A8DFBC-52F7-4582-9B36-7535BCD2D64EQ38203172-B3BBE8E5-FEF6-4F13-AB80-BCDFD62953DDQ38763327-C9AECE1B-BB33-4190-9A77-FC0FE02D5173Q39229285-952AF7CD-99D8-47CB-A778-405F62D7C9DCQ39361330-C17859FD-18D4-494B-A60F-7EE6280D9241Q39658573-F11E5FED-070B-4A5C-9FF0-2D0C30E3120BQ40092230-ACCD646F-D1ED-4699-874A-C19FDBE52D18Q40168052-597B3D3E-629B-4A51-97CB-EE5A17645E42Q42286490-B4B03D7D-9D47-468F-8078-BBDD6C141762Q46484918-373662CC-8AE8-4974-85C9-D82C326F89A6Q53206105-1893C035-1309-491F-805E-3698D8147269
P2860
Contrasting roles of complement activation and its regulation in membranous nephropathy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Contrasting roles of complement activation and its regulation in membranous nephropathy.
@ast
Contrasting roles of complement activation and its regulation in membranous nephropathy.
@en
type
label
Contrasting roles of complement activation and its regulation in membranous nephropathy.
@ast
Contrasting roles of complement activation and its regulation in membranous nephropathy.
@en
prefLabel
Contrasting roles of complement activation and its regulation in membranous nephropathy.
@ast
Contrasting roles of complement activation and its regulation in membranous nephropathy.
@en
P356
P1476
Contrasting roles of complement activation and its regulation in membranous nephropathy.
@en
P2093
Patrick N Cunningham
Richard J Quigg
P304
P356
10.1681/ASN.2005010096
P577
2005-03-30T00:00:00Z